This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 200-unit vials of the drug Xeomin. The $15,727.50 firm fixed-price contract has an ultimate completion date of August 14, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 200-unit vials of the drug Xeomin. The contract has a firm fixed price of $6,155.52 and a completion date of January 18, 2023. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 200-unit vials of the drug Xeomin. The contract has a firm fixed price of $7,863.60 and a completion date of March 13, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as the primary vehicle for providing a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XEOMIN 100 unit vials. The $10,847.20 firm fixed price contract has a completion date of January 9, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare...
The Defense Logistics Agency (DLA) awarded a $1,425 firm fixed-price delivery order contract to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 50-unit vials of the drug Xeomin. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999, which provides a range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen also holds a...
This is a delivery order worth $3,145.50 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 200-unit vials of the pharmaceutical product Xeomin. The contract has a firm fixed-price pricing structure and a completion date of September 30, 2024. AmerisourceBergen is a large pharmaceutical distributor that holds multiple Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a wide range...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 200-unit vials of the medication Xeomin, with a ceiling value of $83,811.00. The contract is a firm fixed-price delivery order, with an ultimate completion date of July 15, 2025. AmerisourceBergen Drug Corp is a for-profit organization registered in the System for Award...
The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply $12,856.32 worth of Xeomin 100 unit vials. This contract has a firm fixed price and is set to be completed by June 3, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,033.80 firm fixed-price contract is for the delivery of XEOMIN 100 unit vials and has an ultimate completion date of December 9, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of 200-unit vials of the pharmaceutical product XEOMIN, with a ceiling value of $2,234.96 and a period of performance through April 2025. The contract is a firm fixed-price, non-set-aside award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA...